Gut Akkermansia muciniphila ameliorates metabolic dysfunction-associated fatty liver disease by regulating the metabolism of L-aspartate via gut-liver axis

The gut bacterium Akkermansia muciniphila has been increasingly recognized for its therapeutic potential in treating metabolic disorders, including obesity, diabetes, and metabolicdysfunction-associated fatty liver disease (MAFLD). However, its underlying mechanism involved in its well-known metabol...

Descripción completa

Detalles Bibliográficos
Autores principales: Rao, Yong, Kuang, Zhiqi, Li, Chan, Guo, Shiyao, Xu, Yaohao, Zhao, Dandan, Hu, Yutao, Song, Bingbing, Jiang, Zhi, Ge, Zhenhuang, Liu, Xiyuan, Li, Chengdao, Chen, Shuobin, Ye, Jiming, Huang, Zhishu, Lu, Yongjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8158032/
https://www.ncbi.nlm.nih.gov/pubmed/34030573
http://dx.doi.org/10.1080/19490976.2021.1927633

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8158032/
https://www.ncbi.nlm.nih.gov/pubmed/34030573
http://dx.doi.org/10.1080/19490976.2021.1927633

Ejemplares similares